K2M Group Holdings, Inc. (NASDAQ: KTWO) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for BACS® Patient-Specific devices ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE